BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32369230)

  • 41. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
    Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
    J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.
    Tong G; Wu X; Cheng B; Li L; Li X; Li Z; Nong Q; Chen X; Liu Y; Wang S
    Am J Transl Res; 2017; 9(10):4545-4552. PubMed ID: 29118916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma.
    Chen R; Wang X; Zhou S; Zeng Z
    Cancer Manag Res; 2021; 13():5443-5455. PubMed ID: 34267554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knocking Down lncRNA HOXA-AS2 Mitigates the Progression of Epilepsy via Regulation of the miR-372-3p/STAT3 Axis.
    Song L; Li J; Sun Z
    Turk Neurosurg; 2023; 33(5):781-789. PubMed ID: 36482855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNA HOXA-AS2 mediates microRNA-106b-5p to repress sepsis-engendered acute kidney injury.
    Wu H; Wang J; Ma Z
    J Biochem Mol Toxicol; 2020 Apr; 34(4):e22453. PubMed ID: 32048402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HOXA cluster antisense RNA 2 elevates KIAA1522 expression through microRNA-520d-3p and insulin like growth factor 2 mRNA binding protein 3 to promote the growth of vascular smooth muscle cells in thoracic aortic aneurysm.
    Ou M; Chu Y; Zhang Q; Zhao H; Song Q
    ESC Heart Fail; 2022 Oct; 9(5):2955-2966. PubMed ID: 35730141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1α expression.
    Yang X; Zhang Y; Chen Y; He X; Qian Y; Xu S; Gao C; Mo C; Chen S; Xiao Q
    J Neuroinflammation; 2021 Sep; 18(1):197. PubMed ID: 34511122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.
    Li D; Wang D; Liu H; Jiang X
    Bioengineered; 2022 Apr; 13(4):8087-8100. PubMed ID: 35294319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
    Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
    Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer.
    Shi YB; Liu SL; Mou XR; Liao J; Che JP; Fei XQ; Wang AR
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1243-1249. PubMed ID: 32096154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
    Liang X; Xia R
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of HOXA-AS2 LncRNA in Patients with Gastric Cancer and Its Association with Helicobacter pylori Infection.
    Rajabi A; Riahi A; Shirabadi-Arani H; Moaddab Y; Haghi M; Safaralizadeh R
    J Gastrointest Cancer; 2022 Mar; 53(1):72-77. PubMed ID: 33174119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA HOXA-AS2 Activates the Notch Pathway to Promote Cervical Cancer Cell Proliferation and Migration.
    Wu Q; Lu S; Zhang L; Zhao L
    Reprod Sci; 2021 Oct; 28(10):3000-3009. PubMed ID: 34076871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HOXA-AS2 contributes to regulatory T cell proliferation and immune tolerance in glioma through the miR-302a/KDM2A/JAG1 axis.
    Zhong C; Tao B; Li X; Xiang W; Peng L; Peng T; Chen L; Xia X; You J; Yang X
    Cell Death Dis; 2022 Feb; 13(2):160. PubMed ID: 35181676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.
    Fernando TR; Contreras JR; Zampini M; Rodriguez-Malave NI; Alberti MO; Anguiano J; Tran TM; Palanichamy JK; Gajeton J; Ung NM; Aros CJ; Waters EV; Casero D; Basso G; Pigazzi M; Rao DS
    Mol Cancer; 2017 Jul; 16(1):126. PubMed ID: 28724437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA‑339‑5p inhibits cell proliferation of acute myeloid leukaemia by directly targeting SOX4.
    Sun X; Liu H; Li T; Qin L
    Mol Med Rep; 2018 Dec; 18(6):5261-5269. PubMed ID: 30320397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid precursor protein cooperates with c-KIT mutation/overexpression to regulate cell apoptosis in AML1-ETO-positive leukemia via the PI3K/AKT signaling pathway.
    Yu G; Yin C; Jiang L; Zheng Z; Wang Z; Wang C; Zhou H; Jiang X; Liu Q; Meng F
    Oncol Rep; 2016 Sep; 36(3):1626-32. PubMed ID: 27460334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.